1. $5.6 billion – In Re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation , Case No. 20-339 (2d Cir. Mar. 15, 2023) (final settlement approval confirmed on appeal in antitrust class action lawsuit against Visa and Mastercard over interchange fees). 2. $2.67 billion - In Re Blue Cross Blue Shield Antitrust Litigation, Case No. 13-28390 (11th Cir. Oct. 25, 2023) (final settlement approval confirmed on appeal to resolve a class action that alleged that the defendants violated antitrust laws by entering into an agreement not to compete with each other and to limit competition among themselves in selling health insurance and administrative services for health insurance). 3. $750 million – In Re Namenda Direct Purchaser Antitrust Litigation, Case No. 15 Civ. 7488 (S.D.N.Y. Mar. 23, 2023) (final settlement approval granted for a class action alleging that defendants schemed to delay entry of generic versions of an Alzheimer's disease treatment by entering into collusive settlements with various generic drug companies). 4. $700 million - In Re Google Play Store Antitrust Litigation , Case No. 21-MD-2981 (N.D. Cal. Dec. 18, 2023) (settlement reached in a class action and government enforcement lawsuit resolving claims that Google overcharged consumers through unlawful restrictions on the distribution of apps on Android devices and unnecessary fees for in-app transactions). 5. $573 million – In Re Zetia (Ezetimibe) Antitrust Litigation, Case No. 18-MD-2836 (E.D. Va. Oct. 18, 2023) (final settlement approval granted for a class action to resolve allegations that Merck conspired with Glenmark Pharmaceuticals to delay the launch of generic versions of the cholesterol drug Zetia).
17
© Duane Morris LLP 2024
Duane Morris Antitrust Class Action Review – 2024
Made with FlippingBook - professional solution for displaying marketing and sales documents online